Report
Quarterly Litigation Status Report- March 2016
Date
File
Quarterly Litigation Status Report (March 2016)
(210.87 KB)
Displaying 1361 - 1380 of 2311
FTC Puts Conditions on Drug Manufacturer Hikma Pharmaceuticals PLC’s Proposed Acquisition of Roxane Laboratories Inc. and Boehringer Ingelheim Roxane, Inc. from Boehringer Ingelheim Corporation
Date
Drug manufacturer Hikma Pharmaceuticals PLC will sell the rights and assets for two generic drugs, and relinquish its U.S. marketing rights to a third generic drug, in order to settle FTC charges that...
FTC Approves Modified Consent Order for Mylan N.V.
Date
The Federal Trade Commission has approved a modified final order settling charges that Mylan N.V.’s proposed hostile takeover of Perrigo Company plc would harm competition. Because Mylan failed to...
FTC Requires Drug Marketer Hikma Pharmaceuticals PLC to Divest Rights to Five Generic Injectable Drugs as a Condition of Acquiring Certain Drug Products from Ben Venue Laboratories, Inc.
Date
The Federal Trade Commission will require generic drug marketer Hikma Pharmaceuticals PLC to divest its rights and interests in five generic injectable pharmaceuticals, as part of a settlement...
FTC Puts Conditions on Generic Drug Marketer Lupin Ltd.’s Proposed Acquisition of Gavis Pharmaceuticals LLC
Date
Generic drug manufacturers Lupin Ltd. and Gavis Pharmaceuticals LLC will sell the rights and assets for two generic drugs, one used to treat bacterial infections and the other to treat ulcerative...
FTC Amicus Brief Urges Appeals Court to Correct District Court Holding that Proving Injury-in-Fact Is Necessary to Establish an Antitrust Violation
Date
The Federal Trade Commission filed an amicus brief in the U.S. Court of Appeals for the First Circuit urging the court to correct the district court’s holding that a plaintiff must prove an injury-in...
FTC Submits Fiscal Year 2017 Budget Request, Performance Plan, and Fiscal Year 2015 Performance Report to Congress
Date
The Federal Trade Commission has submitted to Congress its Fiscal Year 2017 budget request, which includes the FY 2017 Budget Overview Statement, Performance Plan for FY 2016 and FY 2017, and...
FTC Announces Schedule for Reviewing Regulations
Date
As part of the Federal Trade Commission’s systematic review of all current FTC rules and guides, the agency is announcing a modified 10-year regulatory review schedule. To ensure that its rules and...
FTC Approves Final Order Preserving Competition in Three Pennsylvania Terminal Markets for Light Petroleum Products
Date
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that energy investor ArcLight Energy Partners Fund VI, L.P.’s acquisition of Gulf Oil...
FTC Commissioner Ohlhausen Testifies Before Senate Judiciary Subcommittee Regarding Occupational Licensing and the State Action Doctrine
Date
In testimony presented to a U.S. Senate Judiciary subcommittee, the Federal Trade Commission described its competition enforcement and advocacy work relating to state regulatory boards and licensing...
FTC Staff Comment: Proposed Dental Services Measure in Georgia Would Likely Enhance Competition and Increase Access to Care for Consumers
Date
Federal Trade Commission staff submitted a comment regarding proposed legislation that would broaden the types of settings under which Georgia dental hygienists are allowed to provide preventive care...
FTC Approves Final Order Settling Charges that Commercial Trucking Services Company Invited Competitor to Allocate Customers
Date
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Drug Testing Compliance Group, LLC, an Idaho-based company that provides drug and...
FTC Approves Final Order Preserving Competition in Worldwide Market for RF Power Amplifiers
Date
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that NXP Semiconductors N.V.’s $11.8 billion acquisition of Freescale Semiconductor Ltd...
FTC Announces New Clayton Act Monetary Thresholds for 2016
Date
As required by law, the Federal Trade Commission has revised the monetary thresholds that determine whether companies are required to notify federal antitrust authorities about a transaction under...
FTC Report on Drug Patent Settlements Shows Potential Pay-for-Delay Deals Decreased Substantially in the First Year Since Supreme Court’s Actavis Decision
Date
Pharmaceutical companies entered into substantially fewer potential pay-for-delay patent dispute settlements in fiscal year 2014, according to a new FTC staff report. The report summarizes data on...
FTC Announces Agenda and Panelists for Workshop Examining the U.S. Auto Distribution System
Date
The Federal Trade Commission has announced the full agenda for its upcoming workshop, “Automobile Distribution: Current Issues and Future Trends.” The all-day event, which will take place on January...
FTC Requires Kidney Dialysis Chain U.S. Renal Care to Divest Assets as a Condition of Acquiring Competitor DSI Renal
Date
The Federal Trade Commission will require the national kidney-dialysis chain U.S. Renal Care, Inc., for which Rangers Renal Holdings LP is the parent company, to divest its ownership interest in three...
FTC Requires Energy Investor ArcLight Energy Partners Fund to Divest Assets as a Condition of Acquiring Gulf Oil Limited Partnership from Cumberland Farms, Inc.
Date
The Federal Trade Commission will require energy investor ArcLight Energy Partners Fund VI, L.P., to divest its ownership interest in four light petroleum product terminals in Pennsylvania, as part of...
FTC Approves Final Order Settling Charges that Merger of Orthopedic Practices in Berks County, Pennsylvania Would Likely Harm Competition and Inflate Prices
Date
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that a merger combining 76 percent of the orthopedists in Berks County, PA into Keystone...
Displaying 1361 - 1380 of 2311